UnitedHealth Group Incorporated $UNH Shares Sold by Consolidated Planning Corp

Consolidated Planning Corp decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 38.5% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 840 shares of the healthcare conglomerate’s stock after selling 525 shares during the quarter. Consolidated Planning Corp’s holdings in UnitedHealth Group were worth $262,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the business. Retirement Planning Group LLC raised its holdings in UnitedHealth Group by 5.1% in the 1st quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate’s stock worth $225,000 after purchasing an additional 21 shares during the period. Net Worth Advisory Group raised its holdings in shares of UnitedHealth Group by 0.6% during the first quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate’s stock valued at $1,907,000 after acquiring an additional 21 shares during the last quarter. Bensler LLC raised its holdings in shares of UnitedHealth Group by 0.3% during the first quarter. Bensler LLC now owns 6,945 shares of the healthcare conglomerate’s stock valued at $3,637,000 after acquiring an additional 22 shares during the last quarter. Lakeridge Wealth Management LLC raised its holdings in shares of UnitedHealth Group by 5.8% during the first quarter. Lakeridge Wealth Management LLC now owns 420 shares of the healthcare conglomerate’s stock valued at $220,000 after acquiring an additional 23 shares during the last quarter. Finally, Broadway Wealth Solutions Inc. raised its holdings in shares of UnitedHealth Group by 2.1% during the first quarter. Broadway Wealth Solutions Inc. now owns 1,151 shares of the healthcare conglomerate’s stock valued at $603,000 after acquiring an additional 24 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on UNH shares. Wells Fargo & Company reduced their target price on UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating for the company in a report on Monday, August 4th. Truist Financial increased their target price on UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a report on Tuesday, September 9th. JPMorgan Chase & Co. cut their price target on UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating for the company in a report on Wednesday, August 6th. Morgan Stanley increased their price target on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a report on Friday, September 12th. Finally, UBS Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Sixteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $358.95.

UnitedHealth Group Trading Up 1.4%

Shares of UnitedHealth Group stock opened at $353.26 on Friday. The firm has a market capitalization of $319.94 billion, a price-to-earnings ratio of 15.31, a PEG ratio of 2.27 and a beta of 0.47. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a 50 day moving average of $306.25 and a 200 day moving average of $356.57.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company’s revenue was up 12.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.